Clinical Immunoassays Market By Product (Immunoanalyzers, Reagents, and Kits) By Application (Cancer Testing/ Diagnostics, Cardiovascular Diagnostics, Others) By End-Users (Hospitals, Laboratories, Others) Regional Analysis & Forecast to 2026
- OI-88 |
- Published date: Mar, 2019 |
- In Vitro Diagnostics |
- Pages
An immunoassay is an analytical method used to detect health problems or conditions based on the reaction of an antigen or antibody. Immunoassays rely on an analysis of the immunological properties of the analytes. Immunoassay techniques, which are sensitive and specific tests, are used in disease diagnosis, therapeutic drug monitoring and pharmacokinetic and bioequivalence studies in the fields of drug discovery and the pharmaceutical industry.
Market Overview
Segmentation
By Product Type: Immunoanalyzers, Reagents, and Kits.
By-product and service, the market is segmented into reagents and immuno analyzers, kits, and software. The immunoassay reagents and kits segment accounted for the largest share of this market in 2018.
By Application: Cancer testing/ diagnostics, Cardiovascular Diagnostics, Infectious disease diagnostics, Bone and Mineral diagnostics, Endocrinology, Diabetes Testing, Autoimmune disease diagnostics, Drug of Abuse Testing and Others.
By End-users: Hospitals, Laboratories, Academics, Others
By Geography: North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).
The Asia Pacific is anticipated to register the highest rate of growth over the forecast time period. According to the WHO (World Health Organization), about half of children’s deaths were caused by infections. The WHO also estimated that about 1 million new cases of tuberculosis are registered in China. North America dominates the market due to the technological advancement in immunoassay products and rising incidence of chronic diseases like cardiovascular and thyroid diseases.
The report includes in-depth company profiles of key players in Clinical Immunoassays Market. The company profile includes key information on overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Scope:
- Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Clinical Immunoassays Market
- Provides a comparative analysis of key marketed products and pipeline Clinical Immunoassays market products
- Provides key information on players involved on the Clinical Immunoassays Market
- Provides a complete overview of market segments and the regional outlook of Clinical Immunoassays Market
- Provides in-depth coverage of key news related to Clinical Immunoassays Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates
Our research works on a holistic 360° approach to deliver high quality, validated and reliable information in our market reports. Market estimation and forecasting involve the following steps:
-
Data Collation (Primary & Secondary)
-
In-house Estimation (Based on proprietary databases and Models)
-
Market Triangulation
-
Forecasting
-
Market-related information is assembled from both primary and secondary sources.
- Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
- Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
- Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
